Evolution of HIV and HCV coinfected children receiving long-term lopinavir/ritonavir-based antiretroviral therapy

被引：0
作者：
Larru, Beatriz [1 ]
Resino, Salvador [1 ,2 ]
Bellon, Jose M. [1 ]
Isabel de Jose Gomez, M. [3 ]
Fortuna, Claudia [4 ]
Munoz-Fernandez, M. Angeles [1 ]
机构：
[1] Hosp Gen Univ Gregorio Maranon, Lab Inmunobiol Mol, Madrid 28007, Spain
[2] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain
[3] Hosp Univ La Paz, Serv Inmunopediat, Madrid, Spain
[4] Hosp San Joan de Deu, Serv Inmunopediat, Barcelona, Spain
来源：
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2008年 / 26卷 / 07期
关键词：
HIV; HCV; LPV/r; HAART; children;
D O I：
10.1157/13125640
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
INTRODUCTION. There are few studies investigating the effect of HCV coinfection on HIV-related disease among children. METHODS. We studied 5 HIV/HCV coinfected children receiving an LPV/r-containing HAART regimen. Their evolution was compared with a control group of 72 HIV-infected children. RESULTS. All 5 HIV/HCV-coinfected children achieved sustained immune recovery during the study. Moreover, they showed better viral suppression than the control group. None of the 5 HIV/HCV-coinfected children experienced any adverse effects with the use of LPV/r. CONCLUSION. HIV/HCV coinfection does not reduce the benefits obtained from HAART.
引用
收藏
页码：426 / 429
页数：4
相关论文
共 50 条
  • [21] Long-Term Outcomes and Risk Factors for Mortality in a Cohort of HIV-Infected Children Receiving Antiretroviral Therapy in Vietnam
    Rang Ngoc Nguyen
    Quang Chanh Ton
    My Huong Luong
    Ly Ha Lien Le
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2020, 12 : 779 - 787
  • [22] Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort
    Amani-Bosse, Clarisse
    Dahourou, Desire Lucien
    Malateste, Karen
    Amorissani-Folquet, Madeleine
    Coulibaly, Malik
    Dattez, Sophie
    Emieme, Arlette
    Barry, Mamadou
    Rouzioux, Christine
    N'gbeche, Sylvie
    Yonaba, Caroline
    Timite-Konan, Marguerite
    Mea, Veronique
    Ouedraogo, Sylvie
    Blanche, Stephane
    Meda, Nicolas
    Seguin-Devaux, Carole
    Leroy, Valeriane
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2017, 20
  • [23] Accelerated Suppression of Primary Epstein-Barr Virus Infection in HIV-Infected Infants Initiating Lopinavir/Ritonavir-Based Versus Nevirapine-Based Combination Antiretroviral Therapy
    Slyker, Jennifer A.
    Casper, Corey
    Tapia, Kenneth
    Richardson, Barbra
    Bunts, Lisa
    Huang, Meei-Li
    Wamalwa, Dalton
    Benki-Nugent, Sarah
    John-Stewart, Grace
    CLINICAL INFECTIOUS DISEASES, 2014, 58 (09) : 1333 - 1337
  • [24] Plasma metabolic changes in Chinese HIV-infected patients receiving lopinavir/ritonavir based treatment: Implications for HIV precision therapy
    Li, Xiaolin
    Wu, Tong
    Jiang, Yongjun
    Zhang, Zining
    Han, Xiaoxu
    Geng, Wenqing
    Ding, Haibo
    Kang, Jing
    Wang, Qi
    Shang, Hong
    CYTOKINE, 2018, 110 : 204 - 212
  • [25] Long-term immune and virological response in HIV-infected patients receiving antiretroviral therapy
    Silveira, M. P. T.
    Silveira, C. P. T.
    Guttier, M. C.
    Page, K.
    Moreira, L. B.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (06) : 689 - 694
  • [26] Genotypic Resistance at Viral Rebound Among Patients Who Received Lopinavir/Ritonavir-Based or Efavirenz-Based First Antiretroviral Therapy in South Africa
    Dlamini, J. Nomthandazo
    Hu, Zonghui
    Ledwaba, Johanna
    Morris, Lynn
    Maldarelli, Frank M.
    Dewar, Robin L.
    Highbarger, Helene C.
    Somaroo, Harsha
    Sangweni, Phumelele
    Follmann, Dean A.
    Pau, Alice K.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 58 (03) : 304 - 308
  • [27] Factors associated with clinical, immunological and virological responses in protease-inhibitor-experienced Brazilian children receiving highly active antiretroviral therapy containing lopinavir-ritonavir
    Machado, Daisy Maria
    Barbosa Gouvea, Aida de Fatima
    Cardoso, Maria Regina
    Beltrao, Suenia Vasconcelos
    Cunegundes, Kelly Simone
    Bononi, Fabiana
    Almeida, Fernanda
    Cavalheiro, Kaline
    Araujo de Angelis, Daniela Souza
    de Menezes Succi, Regina Celia
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (01) : 16 - 19
  • [28] Long-term effect of antiretroviral therapy on mortality among HIV-positive children and adolescents in China
    Zhang, Hanxi
    Lao, Xiaojie
    Li, Huiqin
    Lu, Hongyan
    Cheng, Yuewu
    Song, Yuxia
    Zhao, Qingxia
    Chen, Jinfeng
    Ye, Fuxiu
    Zhao, Hongxin
    Zhang, Fujie
    HELIYON, 2024, 10 (07)
  • [29] Long-term survival outcomes of HIV infected children receiving antiretroviral therapy: an observational study from Zambia (2003–2015)
    Jane N. Mutanga
    Simon Mutembo
    Amara E. Ezeamama
    Xiao Song
    Robert C. Fubisha
    Kunda Mutesu-Kapembwa
    Derrick Sialondwe
    Brenda Simuchembu
    Jelita Chinyonga
    Philip E. Thuma
    Christopher C. Whalen
    BMC Public Health, 19
  • [30] Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland
    Trinh Duong
    Judd, Ali
    Collins, Intira Jeannie
    Doerholt, Katja
    Lyall, Hermione
    Foster, Caroline
    Butler, Karina
    Tookey, Pat
    Shingadia, Delane
    Menson, Esse
    Dunn, David T.
    Gibb, Di M.
    AIDS, 2014, 28 (16) : 2395 - 2405
12345